Non hodgkin's lymphoma News

THURSDAY, Nov. 24 (HealthDay News) -- Higher doses of chemotherapy with less time between treatments may benefit younger people suffering from aggressive lymphomas, such as diffuse large B-cell lymphoma (one of the most common and aggressive forms...

TUESDAY, May 10 (HealthDay News) -- Those who take acetaminophen -- best known as Tylenol -- regularly for some time might be putting themselves at an increased risk for developing certain blood cancers, University of Washington researchers report...

TUESDAY, April 19 (HealthDay News) -- New research suggests a link between breast implants and a rare form of lymphoma, but it's not known if the implants actually cause the cancer or how the disease might develop. The researchers, from the nonpro...

WEDNESDAY, Dec. 22 (HealthDay News) -- Researchers have identified a gene mutation that may offer a target for new treatments for a type of lymphoma. The team found that a mutation of the MYD88 gene is one of the most frequent genetic abnormalitie...

TUESDAY, Dec. 21 (HealthDay News) -- New research provides more evidence that treating certain lymphoma patients with an expensive drug over the long term helps them go longer without symptoms. But the drug, called rituximab (Rituxan), does not se...

WEDNESDAY, June 9 (HealthDay News) -- Children born to older fathers are at increased risk for non-Hodgkin's lymphoma, a new study has found. Researchers analyzed data on 110,999 California women and found that those born to fathers older than 40 ...

THURSDAY, March 11 (HealthDay News) -- Seaweed extract has the potential to become a treatment for the immune system cancer known as lymphoma, according to the results of preliminary research. In the study, researchers experimented with compounds ...

WEDNESDAY, Jan. 6 (HealthDay News) -- New research into the genetic causes of a form of non-Hodgkin's lymphoma could lead to novel treatments, suggest researchers from the U.S. National Institutes of Health. Their new study reports on how lymphoma...

FRIDAY, Nov. 6 (HealthDay News) -- The Gloucester Pharmaceuticals drug Istodax (romidepsin) has been approved by the U.S. Food and Drug Administration to treat cutaneous T-cell lymphoma (CTCL) in people who have tried at least one prior systemic t...

WEDNESDAY, Oct. 7 (HealthDay News) -- The weakened immune systems of people with HIV puts them at increased risk for at least seven types of cancer, but early diagnosis and treatment of HIV infection could help delay the onset of some of these can...

FRIDAY, Sept. 25 (HealthDay News) -- The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday. The drug, giv...

THURSDAY, Aug. 27 (HealthDay News) -- American teens and young adults newly diagnosed with blood-related cancers now live longer than they did in the 1980s, new research has found. Researchers analyzed data from the Surveillance, Epidemiology and ...

SUNDAY, May 31 (HealthDay News) -- In a new study, patients with follicular non-Hodgkin lymphoma who received a vaccine made from their own cancer cells went more than 44 months before relapsing, compared to only 30.6 months for those who didn't g...

TUESDAY, April 21 (HealthDay News) -- Patients with non-Hodgkin lymphoma who drank wine before their diagnosis appeared to have a reduced risk of relapse or death, according to a study that's the first to identify this connection. The researchers ...